Works matching IS 0008543X AND DT 2014 AND VI 120 AND IP 3


Results: 26
    1
    2
    3
    4

    HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 3, p. 373, doi. 10.1002/cncr.28433
    By:
    • Strati, Paolo;
    • Kantarjian, Hagop;
    • Thomas, Deborah;
    • O'Brien, Susan;
    • Konoplev, Sergej;
    • Jorgensen, Jeffrey L.;
    • Luthra, Raja;
    • Abruzzo, Lynne;
    • Jabbour, Elias;
    • Quintas‐Cardama, Alfonso;
    • Borthakur, Gautam;
    • Faderl, Stefan;
    • Ravandi, Farhad;
    • Cortes, Jorge
    Publication type:
    Article
    5
    6

    Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 3, p. 381, doi. 10.1002/cncr.28352
    By:
    • Bao, Ting;
    • Cai, Ling;
    • Snyder, Claire;
    • Betts, Kelly;
    • Tarpinian, Karineh;
    • Gould, Jeff;
    • Jeter, Stacie;
    • Medeiros, Michelle;
    • Chumsri, Saranya;
    • Bardia, Aditya;
    • Tan, Ming;
    • Singh, Harvinder;
    • Tkaczuk, Katherin H. R.;
    • Stearns, Vered
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26